| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-11 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 2e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |